Search

Your search keyword '"Young, Allan"' showing total 480 results

Search Constraints

Start Over You searched for: Author "Young, Allan" Remove constraint Author: "Young, Allan" Database Complementary Index Remove constraint Database: Complementary Index
480 results on '"Young, Allan"'

Search Results

1. Non- Helicobacter pylori Helicobacters , a Treatable Provocateur of Parkinson's Disease: Hypothesis, Evidence and Species Specificity.

2. The duration of lithium use and biological ageing: telomere length, frailty, metabolomic age and all-cause mortality.

3. Olanzapine for young PEople with aNorexia nervosa (OPEN): results of a feasibility study.

6. Home-based transcranial direct current stimulation in bipolar depression: an open-label treatment study of clinical outcomes, acceptability and adverse events.

7. Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine benzoate) in healthy participants.

8. The effect of a low-calorie diet on depressive symptoms in individuals with overweight or obesity: a systematic review and meta-analysis of interventional studies.

9. Olanzapine for young PEople with aNorexia nervosa (OPEN): A protocol for an open‐label feasibility study.

10. Commentary on the Canadian Network for Mood and Anxiety Treatments 2023 Clinical Guidelines for Management of Major Depressive Disorder in Adults – Capturing the State of the Art.

11. Is it now time to prepare psychiatry for a psychedelic future?

12. Antidepressants and Bipolar Disorder: The Plot Thickens.

13. Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effects.

14. A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study.

15. Patterns of pharmacotherapy for bipolar disorder: A GBC survey.

16. Lithium: how low can you go?

17. Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report.

19. Psychedelics for treatment resistant depression: are they game changers?

20. The 5-HT7 receptor system as a treatment target for mood and anxiety disorders: A systematic review.

21. Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights.

22. Investigating the role of the relaxin-3/RXFP3 system in neuropsychiatric disorders and metabolic phenotypes: A candidate gene approach.

23. Cognitive Remediation in Bipolar (CRiB2): study protocol for a randomised controlled trial assessing efficacy and mechanisms of cognitive remediation therapy compared to treatment as usual.

25. Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life.

26. Bradyphrenia and Tachyphrenia in Idiopathic Parkinsonism Appear, in Part, Iatrogenic: An Observational Study with Systematic Review Background.

27. Role of trazodone in treatment of major depressive disorder: an update.

28. Is there a 'bipolar iceberg' in UK primary care psychological therapy services?

29. The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank.

30. A transdiagnostic systematic review and meta-analysis of ketamine's anxiolytic effects.

31. Acceptability, Tolerability, and Estimates of Putative Treatment Effects of Probiotics as Adjunctive Treatment in Patients With Depression: A Randomized Clinical Trial.

32. An Expert Roundtable Discussion on the Use of Classic Monoamine Oxidase Inhibitors in the Treatment of Depression – Part One.

33. Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.

34. The interaction between kynurenine pathway, suicidal ideation and augmentation therapy with minocycline in patients with treatment-resistant depression.

35. Child and adolescent anxiety as a risk factor for bipolar disorder: A systematic review of longitudinal studies.

36. Profile of sleep disturbances in patients with recurrent depressive disorder or bipolar affective disorder in a tertiary sleep disorders service.

37. Clinicians' preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force.

38. Self-blame in major depression: a randomised pilot trial comparing fMRI neurofeedback with self-guided psychological strategies.

41. Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology.

42. Plus ça change? Switching lithium preparations.

43. The effects of reserpine on depression: A systematic review.

44. Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression.

45. Recent advances in the psychopharmacology of major depressive disorder.

46. Does cognitive improvement translate into functional changes? Exploring the transfer mechanisms of cognitive remediation therapy for euthymic people with bipolar disorder.

47. Antidepressant and antipsychotic treatment of Psychotic Major Depression in a British mental healthcare setting.

48. Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations.

49. Group Cognitive Behavioural Therapy for Non-Rapid Eye Movement Parasomnias: Long-Term Outcomes and Impact of COVID-19 Lockdown.

50. A randomised controlled trial to investigate the clinical effectiveness and cost effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) for depressed non-responders to Increasing Access to Psychological Therapies (IAPT) high-intensity therapies: study protocol

Catalog

Books, media, physical & digital resources